Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             418 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A blessing in disguise: Resolution of left hemichorea following a right pontine infarct stroke Fong, P.S.

79 S1 p. e108-e109
artikel
2 Abstracts of the IAPRD XXV World Congress on Parkinson's Disease and Related Disorders, 2020. Congress theme: Diagnosing and treating movement disorders in the era of personalized medicine Fujioka, Shinsuke

79 S1 p. e1-e2
artikel
3 A case of unusual cerebellar ataxia Spanel, P.

79 S1 p. e114
artikel
4 A comparative study of the diagnostic potential of plasma and erythrocytic α-synuclein in Parkinson's disease Wang, L.

79 S1 p. e11
artikel
5 A critical review of cognitive rehabilitation effects on cognition and brain in Parkinson's disease Rakhimova, M.

79 S1 p. e125
artikel
6 Acrylamide induced Parkinson's like neurobehavioral abnormalities in adult Zebrafish via gut brain axis Singh, A.

79 S1 p. e21
artikel
7 Activated endolysosomal cation channel TRPML1 reduces α-synuclein load in a cellular model for Parkinson's Disease Pollmanns, M.R.

79 S1 p. e3
artikel
8 Acute dystonia after using single dose paroxetine: Case report Demirel, E. Aciman

79 S1 p. e106-e107
artikel
9 A double whammy: Essential tremor and Parkinson's disease Rakhimov, F.

79 S1 p. e84
artikel
10 Advancing treatment for CSF1R-related leukoencephalopathy Tipton, P.

79 S1 p. e97
artikel
11 Adverse events and quality of life in advanced Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion therapy Premzl, M.

79 S1 p. e66
artikel
12 Alexithymia, depression, and cognition in patients with Parkinson's disease Kenangil, G.

79 S1 p. e17-e18
artikel
13 Altered cardiovascular function and muscular strength in Parkinson's Disease Alomari, M.

79 S1 p. e126
artikel
14 Ampreloxetine (TD-9855), a norepinephrine reuptake inhibitor, in neurogenic orthostatic hypotension associated with synucleinopathies: phase 2 dose-escalation and double-blind efficacy studies Kaufmann, H.

79 S1 p. e83
artikel
15 Analysis of clinical characteristics of substantia nigra hyperechogenicity on de novo patients with Parkinson's disease Li, Y.

79 S1 p. e52
artikel
16 Analysis of dominant and recessive parkinsonism genes in REM sleep behavior disorder Mufti, K.

79 S1 p. e27-e28
artikel
17 Analysis of heterozygous PRKN variants and copy number variations in Parkinson's disease Yu, E.

79 S1 p. e28
artikel
18 Analysis of the suicide gene based-safeguard system for induced pluripotent stem cell-based therapy of Parkinson's disease Kimura, Y.

79 S1 p. e75-e76
artikel
19 An analysis of QTc prolongation and associated factors in Parkinson's disease patients Malkiewicz, J.

79 S1 p. e42
artikel
20 Anatomical substrates for neuropsychiatric symptoms in patients with Huntington's Disease Kamble, N.

79 S1 p. e107
artikel
21 Anodal transcranial direct current stimulation could modulate cortical excitability reflecting central cholinergic dysfunction Jang, W.

79 S1 p. e71
artikel
22 A novel small molecule tyrosine kinase inhibitor (GUtinib) preferentially targets discoidin domain receptors and reduces toxic proteins in neurodegeneration Moussa, C.

79 S1 p. e67
artikel
23 A potential control of Parkinson's by administering sodium potassium ATPase activity using Prazosin and Propranolol Sinha, S.

79 S1 p. e69
artikel
24 A progressive bradykinesia with dysphagia patient diagnosed as primary lateral sclerosis Park, J.

79 S1 p. e121
artikel
25 A prospective, double-blinded randomized controlled trial evaluating deep brain stimulation using multiple-source, constant-current rechargeable system for Parkinson's Disease: 3-year follow-up Vitek, J.

79 S1 p. e39-e40
artikel
26 A prospective investigation of clinical profile and outcome among hospitalized patients with Parkinson's disease (PD) Biswas, D.

79 S1 p. e94
artikel
27 A rare disease with atypical clinical and imaging findings: Anti LGI-1 encephalitis Keskin, I.

79 S1 p. e12
artikel
28 A rare movement disorder in young population: Holmes tremor Tanriverdi, Z.

79 S1 p. e115
artikel
29 Are functional movement disorder phenotypes or age at onset correlated with perfectionist personality trait or history of abuse? Mehanna, R.

79 S1 p. e118
artikel
30 Are there any autoimmune features on the different stages of Parkinson's disease (PD)? Goncharova, Z.

79 S1 p. e14
artikel
31 Artificial neural networks and the path to diagnosing Parkinson's Disease Jaber, B.

79 S1 p. e9
artikel
32 A single-cell map for the transcriptomic signatures of peripheral blood mononuclear cells in Parkinson's disease He, Y.

79 S1 p. e76
artikel
33 Assessment of association of BDNF rs6265 polymorphism with apathy in Parkinson's Disease Gorzkowska, A.

79 S1 p. e32
artikel
34 Assessment of depressive conditions in Parkinson's disease (PD) and the impact on the quality of life of patients Ismatov, A.

79 S1 p. e26
artikel
35 Assessment of L-Dopa induced dyskinesia Assatullaev, G.

79 S1 p. e103
artikel
36 Assessment of sleep disorders in Parkinson's disease (PD) and the impact on indicators of quality of life Tolibov, D.

79 S1 p. e21
artikel
37 Assessments of plasma acyl-ghrelin levels and body weight in advanced Parkinson's disease after subthalamic nucleus deep brain stimulation Górecka-Mazur, A.

79 S1 p. e14
artikel
38 Associates of mid-brain atrophy in high level gait disorders Sharma, J.

79 S1 p. e100-e101
artikel
39 Association between Parkinsonian subtype Multiple System Atrophy and Anti-Glutamic Acid Decarboxylase antibodies in Stiff Person Spectrum Disorder (SPSD). Case Report Trillo Alvarez, W.

79 S1 p. e98
artikel
40 Association of ADAM10 gene variants with sporadic Parkinson's disease in Chinese Han population Zhou, M.

79 S1 p. e32
artikel
41 Association of dopamine receptor gene polymorphism with the risk of Parkinson's Disease Borgohain, R.

79 S1 p. e31-e32
artikel
42 Association of dopamine transporter gene polymorphisms with the risk of Parkinson's Disease Syed, T.

79 S1 p. e29
artikel
43 Association of potential premotor clinical features with family history in Parkinson's disease Demirelli, D. Selcuk

79 S1 p. e36
artikel
44 Association of potential premotor clinical features with subtypes of motor symptoms in Parkinson's disease Genc, G.

79 S1 p. e34
artikel
45 Associations between physical activity and domain-specific cognitive functions in people with Parkinson's disease Cekok, F.K.

79 S1 p. e23
artikel
46 Ataxia project in Scania, Sweden: Study outline and current status Gorcenco, S.

79 S1 p. e112
artikel
47 Attainment of physiologic salivary flow rate with long-term incobotulinumtoxinA treatment for sialorrhea in Parkinson's disease and other neurologic conditions Pagan, F.

79 S1 p. e85
artikel
48 Atypical phenotype of 3bp deletion and burden analysis of rare variants in the exon 5 of DYT1 in primary dystonia Gu, X.

79 S1 p. e104-e105
artikel
49 Autophagy induction effects in the brain in neurotoxic model of Parkinson's Disease in mice Sabirova, A.

79 S1 p. e3-e4
artikel
50 Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS): The classical clinical manifestations, fundoscopic examination, and brain MRI findings Srikajon, J.

79 S1 p. e113
artikel
51 A validation study for the Subjective Cognitive Decline Questionnaire for Parkinson's Disease (SCDQ-PD) Ha, J.

79 S1 p. e41
artikel
52 A 65-year old female with movement disorder Li, X.-Y.

79 S1 p. e117
artikel
53 Balance and gait disturbances and the quality of life in patients with idiopathic Parkinson's disease and progressive supranuclear palsy Boz, H. Eraslan

79 S1 p. e126
artikel
54 Behavioral manifestations during REM sleep in idiopathic REM sleep behavior disorder Nepozitek, J.

79 S1 p. e6
artikel
55 Billing anomaly in PD: Exploiting DBS in the US fee-for-service reimbursement model Mari, Z.

79 S1 p. e50
artikel
56 Biochemical analysis of changes in serum parameters in Parkinson's disease Ergashov, S.

79 S1 p. e7
artikel
57 Biomarkers for Parkinson's Disease with reflex tears correlate with disease duration Lew, M.

79 S1 p. e5-e6
artikel
58 Biopsychosocial aspect of patients with X-Linked Dystonia Parkinsonism: Its implications on quality of life Alcachupas, A.

79 S1 p. e100
artikel
59 Blood hexokinase reduction in de novo Parkinson's disease and remodeling of glycolytic energy homeostasis with L-DOPA/Istradefylline combination therapy Kanzato, N.

79 S1 p. e68-e69
artikel
60 Blood pressure lability is associated with subcortical atrophy in early Parkinson's disease Yoo, S.-W.

79 S1 p. e9-e10
artikel
61 Blood α-synuclein level as a potential peripheral marker of Parkinson's disease phenotype Banerjee, R.

79 S1 p. e76
artikel
62 BouNDless: An active-controlled, randomised, double-blind, double-dummy trial of continuous subcutaneous infusion of levodopa/carbidopa with ND0612 in patients with Parkinson's disease Rascol, O.

79 S1 p. e53
artikel
63 Brain magnetic resonance imaging and severity of neurological disease in Wilson's disease Litwin, T.

79 S1 p. e97
artikel
64 Brain microstructural changes are related to specific PD phenotypes Minsterová, A. Šejnoha

79 S1 p. e6
artikel
65 Brain networks associated with fatigue in Parkinson's disease Kang, S.Y.

79 S1 p. e10
artikel
66 Brain structures related with motor reserve in Parkinson's Disease using data-driven clustering Youn, J.

79 S1 p. e4-e5
artikel
67 Cardiac dysautonomia in Parkinson's Disease Carwin, A.

79 S1 p. e91
artikel
68 Cardiac sympathetic dysfunction associated with dopaminergic depletion in striatal subregions in de novo Parkinson's disease Umehara, T.

79 S1 p. e38
artikel
69 Cardiac symptoms in cases of neurodegeneration associated with mutations in C19orf12 Skowronska, M.

79 S1 p. e116
artikel
70 Carotid intima-media thickness in Parkinson's disease: a retrospective case control-study Soto-Rincón, C.A.

79 S1 p. e38
artikel
71 Carrier mediated delivery system bearing dopamine for effective management of Parkinsonism Bhargava, M.

79 S1 p. e65
artikel
72 Cases of Parkinson's syndrome in patients with migraine Gulova, M.

79 S1 p. e96
artikel
73 Cerebral glucose metabolism and cognition in Parkinson's disease Kim, S.J.

79 S1 p. e80
artikel
74 Cervical dystonia: from pathophysiology to pharmacotherapy Kholmuratova, B.

79 S1 p. e106
artikel
75 Characteristics and medical history in advanced- vs non-advanced Parkinson's disease: an analysis of intercountry differences in the OBSERVE-PD observational study Fasano, A.

79 S1 p. e44
artikel
76 Characteristics, treatment patterns and disease burden of people with Parkinson's disease in the Parkinson's disease real-world impact assessment (PRISM) study Foltynie, T.

79 S1 p. e86
artikel
77 Characterization of diagnostic certainty levels and clinical syndromes in patients with progressive supranuclear palsy in two German prospective cohorts Iankova, V.

79 S1 p. e96-e97
artikel
78 Chart extraction/clinician survey shows symptom impact and favorable treatment outcomes with VMAT2 inhibitors in patients with Tardive dyskinesia Lundt, L.

79 S1 p. e119
artikel
79 Cholinergic degeneration within a large scale neural network is a major driver of cognitive impairment in Parkinson's disease van der Zee, S.

79 S1 p. e19
artikel
80 Choreoacanthocytosis in a Sri Lankan family presenting with 70% of acanthocytes in a peripheral blood film Sudath, I. Ravindra

79 S1 p. e110
artikel
81 Chronic sleep impairment enhances the susceptibility of LRRK2G2019S mutation induced behavioral abnormality and neuropathology Le, W.

79 S1 p. e94
artikel
82 Clinical and genetic features of five Czech patients with SPG11 Doleckova, K.

79 S1 p. e111
artikel
83 Clinical and neurological features of parkinsonism at young patients with congenital angiodysplasias of brain Kadirova, A.

79 S1 p. e102
artikel
84 Clinical and neurological features of parkinsonism in young patients with chronic obstructive pulmonary disease Kadirova, A.

79 S1 p. e99
artikel
85 Clinical and neurological features of the course of parkinsonism in the presence of chronic renal disease Khudayarova, S.

79 S1 p. e87
artikel
86 Clinical and neurophysiological features and optimization of the treatment of" non-motor "manifestations of Parkinson's disease Davlatbaev, A.

79 S1 p. e95
artikel
87 Clinical assessment of ongoing constipation in patients with Parkinson's disease and solution with alternative approach Rakhimov, O.

79 S1 p. e41-e42
artikel
88 Clinical characteristics of dizzy patients with early Parkinson's disease Kwon, K.-Y.

79 S1 p. e48
artikel
89 Clinical characterization and imaging of electrodes position in DBS of the subthalamic nucleus (STN) in patients with Parkinson's disease Ballesteros, V. Torres

79 S1 p. e5
artikel
90 Clinical correlates of metabolic syndrome in patients with Parkinson's disease Estrada-Bellmann, I.

79 S1 p. e35
artikel
91 Clinical features and frequency of ataxia symptoms and pelvic organs disorders in patients with MS of Uzbek nationality Mirzaeva, D.

79 S1 p. e121-e122
artikel
92 Clinical manifestations of psycho pathology conditions of as non motor symptoms of multiply sclerosis Gulova, M.

79 S1 p. e122
artikel
93 Clinical outcome of spinal cord stimulation for spinal disorder related to Parkinson disease Park, C.K.

79 S1 p. e17
artikel
94 Clinicopathological features of Lewy body disease with dementia pure type Sengoku, R.

79 S1 p. e34-e35
artikel
95 Clinic Research: Role of increasing levels of the hormone cortisol in cognitive impairment in Vascular Parkinsonism Akramova, D.

79 S1 p. e19
artikel
96 Cognition and gait in Parkinson's Disease Fatima, A.

79 S1 p. e25
artikel
97 Cognitive and neurotrophic disturbances in mice transgenic model of parkinson's disease with overexpression of alpha-sinuclein Ergasheva, M.

79 S1 p. e30
artikel
98 Cognitive disorders in patients with Parkinson's Disease. New trends and principles. Analysis report of 40 patients in Uzbekistan Ergasheva, M.

79 S1 p. e23
artikel
99 Cognitive, motor, and autonomic function impairments in idiopathic REM sleep behavior disorder Teigen, L.N.

79 S1 p. e98
artikel
100 Combined effect of repetitive transcranial magnetic stimulation and treadmill training on walking endurance and balance in people with Parkinson's disease Chung, C.

79 S1 p. e64
artikel
101 Comparative evaluation of the effectiveness of group cognitive rehabilitation and relaxation therapy in patients with Parkinson's disease Shokhimardonv, S.

79 S1 p. e83-e84
artikel
102 Compromised cerebral blood vessel wall integrity: role of cerebral microbleeds in Parkinson's disease severity Duarte-Bravo, J.

79 S1 p. e8
artikel
103 Connectivity-based mechanism and response predictors of BoNT treatment for patients with cervical dystonia Feng, L.

79 S1 p. e104
artikel
104 Construct validity of the timed up and go test against cognitive measures in people with Parkinson's disease Cekok, F.K.

79 S1 p. e36
artikel
105 Content validity of MANAGE-PD tool: Real-world evidence from PD patients in G7 countries Fernandez, H.

79 S1 p. e46-e47
artikel
106 Co-occurrence of leukoencephalopathy with ataxia and SPG56 in one family Almasoudi, W.

79 S1 p. e112
artikel
107 Correlation between postoperative reduction of dopaminergic therapy dosage and amount of energy delivered to STN with DBS in PD patients Ibrulj, S.

79 S1 p. e16-e17
artikel
108 Correlation of trinucleotide repeat with SARA score, age of onset and disease duration of genetically-positive spinocerebellar ataxia 2 Filipino family Matibag, J.L.

79 S1 p. e111
artikel
109 Cortico-autonomic association: The structural atrophy central autonomic network correlate with functional attributes of autonomic nervous system in spinocerebellar ataxia patients Tamuli, D.

79 S1 p. e110-e111
artikel
110 Current ICD-10-CM coding does not adequately reflect Parkinson's disease with motor complications Dashtipour, K.

79 S1 p. e80
artikel
111 Deep brain stimulation for Parkinson's disease using motor cortex sensing. Mamatkulov, A.

79 S1 p. e15-e16
artikel
112 Deep brain stimulation withdrawal syndrome: Case report Gunal, D.

79 S1 p. e17
artikel
113 Depression in patients Parkinson's disease; Sri Lankan experience Herath, T.

79 S1 p. e22
artikel
114 Design, characterization and In vivo evaluation of intranasal delivery of levodopa loaded aerosol microspere for Parkinsonism treatment Jain, S.

79 S1 p. e72
artikel
115 Detecting bradykinesia in early morning “OFF” episodes: a large database study using the Personal KinetiGraph® (PKG®) Isaacson, S.

79 S1 p. e88-e89
artikel
116 Determination of non-motor symptoms in Parkinson's disease in Kazakhstan (on the example of the city of Almaty) Aralbayeva, A.

79 S1 p. e91-e92
artikel
117 Determining the safety and feasibility of unilateral cell therapy delivery to the substantia nigra for the goal of disease modification Slevin, J.

79 S1 p. e14
artikel
118 Development and in vivo application of levodopa loaded polylactic co- gylicolic acid (PLGA) nanoparticles for nazal brain drug delivery Comoglu, T.

79 S1 p. e87
artikel
119 Development and validation of a PSP questionnaire as screening tool for early diagnosis of progressive supranuclear palsy (PSP) Höller, E.

79 S1 p. e98-e99
artikel
120 Development and Validation of Catastrophizing and Stigma Scale (CaStS) for Patients with X-Linked Dystonia Parkinsonism Sy, M.A.

79 S1 p. e105-e106
artikel
121 Difference of static postural balance in patients with Parkinson's Disease and scans without evidencec of dopaminergic deficits Kwon, D.-Y.

79 S1 p. e49
artikel
122 Differences in Dopamine Transporter Loss Pattern by FP-CIT SPECT among Parkinson's disease, DLB and Parkinson's disease with dementia Senoo, H.

79 S1 p. e9
artikel
123 Differences of cerebral perfusion between subtype of multiple system atrophy with predominant cerebellar ataxia and with predominant parkinsonism Hirano, S.

79 S1 p. e11
artikel
124 Difficulties with diagnosing Wilson's disease by genetic testing alone Antos, A.

79 S1 p. e100
artikel
125 Dilemma in Parkinson’s Treatment; Levodopa mono-therapy may be the best choice Abbasi, M.H.

79 S1 p. e56
artikel
126 Directional versus omnidirectional Deep Brain Stimulation: Results of a multi-cente prospective blinded crossover study Schnitzler, A.

79 S1 p. e16
artikel
127 Disappearance of familially aggregated paralysis agitans in subsequent generations: a 135-year follow up study Nilsson, K.

79 S1 p. e27
artikel
128 Does carotid intima-media thickness correlate to clinical rating scales in Parkinson's disease? Torres, S.A. Castillo

79 S1 p. e47-e48
artikel
129 Does size matter? Micronutrient intake and impact in lifestyle of patients with Parkinson's disease López-Botello, C.K.

79 S1 p. e81
artikel
130 Do Parkinson's disease people fall more than the general population? A case control study of possible risk factors for falls Thakre, M.

79 S1 p. e80-e81
artikel
131 Do patients with Parkinson's disease adapt their postural response to predictable perturbations induced by a mobile platform? Giardini, M.

79 S1 p. e45
artikel
132 3d printed skull for pre-operative target practice in DBS surgery; helping neurosurgeons adapt to various manufactures of DBS implants Singh, H.

79 S1 p. e15
artikel
133 Dramatic response of coprolalia to dronabinol in Tourette syndrome: A case report Salles, P.

79 S1 p. e109
artikel
134 Durability of effect and safety of open-label ampreloxetine (TD-9855), a norepinephrine reuptake inhibitor, for symptomatic treatment of neurogenic orthostatic hypotension Kaufmann, H.

79 S1 p. e83
artikel
135 Duration of rimabotulinumtoxinB action in the treatment of adult sialorrhea Pagan, F.

79 S1 p. e60
artikel
136 Earlier detection of cerebrovascular disorders in Parkinson's disease Yuldashov, S.

79 S1 p. e103-e104
artikel
137 Effect of an increase in dose of istradefylline, an A2A receptor antagonist, in levodopa-treated patients with Parkinson's Disease (PD) Hattori, N.

79 S1 p. e58
artikel
138 Effect of baseline dyskinesia on safety and efficacy of istradefylline, an A2A receptor antagonist, in Parkinson's disease: 8-study pooled analysis Truong, D.

79 S1 p. e55-e56
artikel
139 Effect of citicoline as adjuvant therapy in Parkinson disease: A systematic review Que, D.-L.

79 S1 p. e67
artikel
140 Effect of cognitive reserve on cognition function in Parkinson's disease: A PRISMA-compliant meta-analysis Gu, L.

79 S1 p. e19
artikel
141 Effect of neurotropic drugs in movement stopping in health and disease Sarkar, S.

79 S1 p. e93-e94
artikel
142 Effects of istradefylline for quality of life in Parkinson's disease with freezing of gait: A singlearm, open-label, prospective, multicenter study Iijima, M.

79 S1 p. e72
artikel
143 Effects of once-daily ampreloxetine (TD-9855), a norepinephrine reuptake inhibitor, on blood pressure in subjects with symptomatic neurogenic orthostatic hypotension Kaufmann, H.

79 S1 p. e79
artikel
144 Effects of primary sensory cortex intermittent theta burst stimulation on motor cortex excitability Kim, J.-Y.

79 S1 p. e78
artikel
145 Effects of vestibular rehabilitation on Parkinson-related fatigue and activities of daily living: A randomized controlled trial Abasi, A.

79 S1 p. e122
artikel
146 Efficacy and safety of IncobotulinumtoxinA in the treatment of lower limb spasticity in Japanese subjects Masakado, Y.

79 S1 p. e117
artikel
147 Efficacy and safety of istradefylline in Parkinson's disease patients with postural abnormality: results from a multicenter open-label study in Japan Takahashi, M.

79 S1 p. e60-e61
artikel
148 Efficacy and safety of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients stratified by baseline Hoehn and Yahr stage Aldred, J.

79 S1 p. e38-e39
artikel
149 Efficacy and safety/tolerability of opicapone in catechol-O-methyltransferase inhibitor-naïve Parkinson's disease patients recently diagnosed with motor fluctuations Lees, A.

79 S1 p. e57
artikel
150 Efficacy of aquatic therapy in rehabilitation of balance, gait & lower extremity function in parkinson's disease - a randomized clinical trial Paramasivam, S.K.

79 S1 p. e124
artikel
151 Efficacy of istradefylline, an A2A receptor antagonist, when added to levodopa and other medications for Parkinson's disease (PD) Le Witt, P.

79 S1 p. e54
artikel
152 Efficacy of opicapone in different treatment regimens in Parkinson's disease patients with motor fluctuations Antonini, A.

79 S1 p. e64-e65
artikel
153 Efficacy of opicapone in Parkinson's patients with motor fluctuations and ON Hoehn & Yahr ≤2.5: post hoc analysis of BIPARK-1 Lew, M.F.

79 S1 p. e58
artikel
154 Efficacy of opicapone in patients with Parkinson's disease with levodopa dose reduction: a pooled post-hoc analysis of BIPARK-I and II Rascol, O.

79 S1 p. e62-e63
artikel
155 Efficacy of opicapone versus entacapone in catechol-O-methyltransferase inhibitor-naïve Parkinson's disease patients recently diagnosed with motor fluctuations: a post-hoc conservative analysis Ferreira, J.J.

79 S1 p. e61
artikel
156 Efficacy/safety of opicapone in Parkinson's disease patients according to duration of motor fluctuations: post-hoc analysis of BIPARK-I and II Ebersbach, G.

79 S1 p. e63-e64
artikel
157 Electrophysiological characteristics of tremor in essential tremor and Parkinson's disease Sabirova, A.

79 S1 p. e115
artikel
158 Electrophysiological markers in early diagnostics of Parkinson's disease Okhunova, D.

79 S1 p. e43
artikel
159 Essential tremor plus syndromes in clinical practice Shiderova, G.

79 S1 p. e114
artikel
160 Estimate outcomes of stroke in controlled and uncontrolled Parkinson's disease: A retrospective cohort study Ibrohimova, N.

79 S1 p. e87
artikel
161 Estimation of Parkinson's disease severity based on voice signal Wójcik-Pędziwiatr, M.

79 S1 p. e46
artikel
162 Etiological factors and imaging findings in hemiballismus in a series of 8 cases Aras, Y. Güzey

79 S1 p. e109
artikel
163 Evaluation of mood symptoms, including anxiety, depression in combination with cognitive impairments in patients with Parkinson's disease Rustamova, C.

79 S1 p. e22-e23
artikel
164 Evaluation of motor response inhibition in Parkinson's Disease and Alzheimer's Disease Rahman, S.

79 S1 p. e86-e87
artikel
165 Evaluation of non-motor symptoms and fluctuations in Parkinson's disease Keskin, I.

79 S1 p. e52-e53
artikel
166 Evaluation of postural tremor of finger for neuromuscular diseases and its application to the classification Kholmuratova, B.

79 S1 p. e116
artikel
167 Evaluation of sleep disturbance in different motor phenotypes of Parkinson's disease Doręgowska, M.

79 S1 p. e35
artikel
168 Evaluations of additive effect of two Indigenous medicinal plants Cedrus Deodara and Mucuna pruriens towards the treatment of Parkinson's Disease Jain, S.

79 S1 p. e64
artikel
169 Experimental simulation of Parkinson's disease with 6-OHDA Toshpulatova, L.

79 S1 p. e13-e14
artikel
170 Exploring linked of age in Parkinson disease Bavaasan, E.

79 S1 p. e48-e49
artikel
171 Exploring motor response inhibition in spino- cerebellar ataxia 12 Siddique, U.

79 S1 p. e111-e112
artikel
172 Exploring reliability and effect sizes of digital biomarkers for Parkinson's disease in the mPower dataset Far, M. Sahandi

79 S1 p. e43
artikel
173 Exposure-response efficacy model of apomorphine sublingual film for the on-demand treatment of “OFF” episodes in patients with Parkinson's disease Agbo, F.

79 S1 p. e85-e86
artikel
174 Feasibility of instrumented low-cost assessment of posture and gait in Parkinson's disease Alvarez, I.

79 S1 p. e50-e51
artikel
175 Features of cognitive disorders in Parkinsonism Masalimova, I.

79 S1 p. e95
artikel
176 Features of gene-gene interactions of MMP3 gene and MMP9 gene in patients with parkinsonism with and without cerebral vascular anomalies Sevara, K.

79 S1 p. e28
artikel
177 Features of the VEGF gene C634 G polymorphism in patients with parkinsonism in the presence of congenital angiodysplasias Gulnora, R.

79 S1 p. e31
artikel
178 Features of tremor in patients with Parkinson's disease Narzieva, Z.

79 S1 p. e115
artikel
179 Fecal level of short chain fatty acids inversely correlated to the motor severity of Parkinson's disease Chen, S.

79 S1 p. e93
artikel
180 Female, Aging, Low ratio of DCI or lower body weight increases AUC4hr of levodopa in patients with Parkinson's disease Nishikawa, N.

79 S1 p. e59
artikel
181 Freezing of gait in Parkinson's disease: A sustained attention failure Mandal, M.

79 S1 p. e24
artikel
182 Frequency of non-motor symptoms presentation in patients with Parkinson disease according to gender and disease stage Abdurakhmonova, K.

79 S1 p. e88
artikel
183 Functional connectivity of the tremor network in essential tremor plus and tremor dominant Parkinson's disease Prasad, S.

79 S1 p. e114
artikel
184 Functional Movement Disorders- a disease with non-organic cause but organic symptoms Banerjee, S.

79 S1 p. e118
artikel
185 Gait and cognition in Parkinson's disease Cheon, S.-M.

79 S1 p. e47
artikel
186 GBA variants in REM sleep behavior disorder risk and conversion: a multicenter study Krohn, L.

79 S1 p. e26
artikel
187 Genetic polymorphism of DA receptors DRD2 and DRD3 and response to non-ergot DA agonist ropinirole in newly diagnosed PD patients Calzetti, S.

79 S1 p. e30
artikel
188 Genetic study in a Turkish family with dopa-responsive dystonia revealed a novel mutation in GCH1 gene Gultekin, M.

79 S1 p. e106
artikel
189 Genotype-phenotype correlations of adult-onset PLA2G6-associated neurodegeneration Lin, C.-H.

79 S1 p. e29
artikel
190 Heads - It's Parkinson's ; Tails - it's cancer, a kindred of Parkinsonism and Malignancies Matta, M.

79 S1 p. e33
artikel
191 Healthcare education program in multiple system atrophy - preliminary results of satisfaction from a national registry based longitudinal study Cámara, A.

79 S1 p. e124
artikel
192 Health related quality of life of Ethiopian Parkinson's disease patients in Addis Ababa, Ethiopia Zewde, Y.

79 S1 p. e82
artikel
193 High caffeine consumption show greater motor progression: a longitudinal study over 9 years Deng, X.

79 S1 p. e34
artikel
194 High cardiovascular risk in patients with Parkinson's disease: a pilot study from northeastern México Flores-Alfaro, F.

79 S1 p. e43
artikel
195 High cost of medications for Parkinson's Disease patients in a rural population of Gujarat, India Desai, S.

79 S1 p. e60
artikel
196 High intensity interval training modulates inflammation markers and miRNAs levels in the serum of patients with idiopathic Parkinson's disease Malczynska, P.

79 S1 p. e123
artikel
197 High satisfaction and improved quality of life with Rock Steady Boxing in Parkinson's Disease Larson, D.

79 S1 p. e76-e77
artikel
198 How Parkinson's disease affects working memory Montaser Kouhsari, L.

79 S1 p. e87-e88
artikel
199 How spatiotemporal gait variables change along the different stages of Hoehn and Yahr scale in Parkinson's disease? Arcolin, I.

79 S1 p. e49
artikel
200 How to strengthen interdisciplinary collaboration? - A mixed-method evaluation of the "Parkinson's Network Muensterland+" Kerkemeyer, L.

79 S1 p. e125-e126
artikel
201 Huntington's disease in adults in Uzbekistan. Qualitative indicators of assisted dying Karimova, M.

79 S1 p. e99-e100
artikel
202 Hydroxytyrosol alleviates Parkinsonism in Caenorhabditis elegans and C57BL/6 mice Pathania, A.

79 S1 p. e59
artikel
203 25 Hydroxyvitamin D levels and gait, posture, and balance in Parkinson's Disease: A retrospective study Spanel, P.

79 S1 p. e90
artikel
204 Hyperglycemic nonketotic chorea with rapid radiological resolution Herath, T.

79 S1 p. e109-e110
artikel
205 Identification of Parkinson's disease via smartphones Goñi, M.

79 S1 p. e44
artikel
206 Identified biomarkers for the development of cognitive impairment in Parkinson's disease Arslon, D.

79 S1 p. e7-e8
artikel
207 Identifying the functional brain network of motor reserve in early Parkinson's disease Chung, S.J.

79 S1 p. e73
artikel
208 Immune mechanisms of depressive disorders in parkinson's disease Shokhimardonv, S.

79 S1 p. e6
artikel
209 Impact of baseline factors on response to apomorphine sublingual film in patients with Parkinson's disease and “OFF” episodes Nicholas, A.

79 S1 p. e85
artikel
210 Impact of botulinum toxin A 'wearing-off' on quality of life in patients with cervical dystonia Ferreira, J.

79 S1 p. e106
artikel
211 Impact of Levodopa/Carbidopa Intestinal Gel Delivery on CarePartner Burden and Quality of Life: Survey by Parkinson & Movement disorder alliance Ospina, M.C.

79 S1 p. e89-e90
artikel
212 Impact of OFF periods on aspects of employment for people with Parkinson's disease Abeynayake, I.

79 S1 p. e89
artikel
213 Impact of race and socioeconomic status on the utilization of advanced therapies in Parkinson's Disease Adrissi, J.

79 S1 p. e77
artikel
214 Improvement of impulse control disorder after subthalamic nucleus deep brain stimulation for the patients with Parkinson's disease Choi, E.J.

79 S1 p. e16
artikel
215 Impulse-control and related behavioural disorder (ICD-RB) due to maladaptive-use of pramipexole in patients of advanced Parkinson's Disease (PD) Gautam, M.

79 S1 p. e20
artikel
216 Impulsive control behaviours in patients with GBA, PARK2 and without mutations in genes associated to Parkinson disease Amami, P.

79 S1 p. e20-e21
artikel
217 IncobotulinumtoxinA to treat sialorrhea in Parkinson's disease: a real-life study Bergmans, B.

79 S1 p. e69-e70
artikel
218 Influence of age of onset on Huntington's disease phenotype Larson, D.

79 S1 p. e108
artikel
219 Influence of levodopa on orthostatic hypotension in Parkinson's disease Jost, W.

79 S1 p. e36
artikel
220 Inspiring neurology residents to specialize in movement disorders Harper, K.

79 S1 p. e121
artikel
221 Intercountry differences in dyskinesia in advanced- vs non-advanced Parkinson's disease: a post hoc analysis of the OBSERVE-PD observational study Fasano, A.

79 S1 p. e39
artikel
222 Intercountry differences in Parkinson's disease treatment in advanced- vs non-advanced Parkinson's disease: post hoc analysis from the OBSERVE-PD observational study Fasano, A.

79 S1 p. e44-e45
artikel
223 Interdisciplinary care of Progressive Supranuclear Palsy from a rehabilitation perspective Murphy, S.

79 S1 p. e123-e124
artikel
224 Interplay of cytokines and nerve-growth factor in patients with Parkinson's Disease: A study in Eastern Indian population Roy, A.

79 S1 p. e84
artikel
225 Intervening effects of orthostatic blood pressure change on subcortical atrophy and cognition in de novo and drug-naïve Parkinson's disease Yoo, S.-W.

79 S1 p. e21
artikel
226 Intranasal delivery of insulin for the restoration of memory signaling in Alzheimer disease Gosain, P.

79 S1 p. e120
artikel
227 Investigating the sensitivity of free-water corrected diffusion-weighted MRI measures to understand sex-specific alterations in Parkinson's disease with mild cognitive impairment Mishra, V.

79 S1 p. e8
artikel
228 In vivo demonstration of selective vulnerability of dopamine neurons Yoo, D.

79 S1 p. e102
artikel
229 In vivo quantification of the locus coeruleus and substantia nigra in parkinson's disease Pape, J.

79 S1 p. e11-e12
artikel
230 Is either hyposmia or constipation associated with cognitive dysfunction in Parkinson's disease? Chang, M.-H.

79 S1 p. e47
artikel
231 Is it now time to routinely include genetic information in decision-making for device-aided therapies in Parkinson disease? Salles, P.

79 S1 p. e90
artikel
232 Is safinamide useful as a levodopa sparing-therapy in Parkinson's disease patients? Dias, M.

79 S1 p. e69
artikel
233 JuTrack: an Android-based application for remote monitoring in neuropsychiatric diseases Far, M. Sahandi

79 S1 p. e42
artikel
234 Kinematic analysis of handwriting in patients of Parkinson's disease using various machine learning algorithms Bhattacharya, A.

79 S1 p. e93
artikel
235 Late-onset cerebellar ataxia due to Gordon Holmes Syndrome Kok, C.-Y.

79 S1 p. e113-e114
artikel
236 L-Dopa induced dyskinesia Tursunov, D.

79 S1 p. e94
artikel
237 L-DOPA products for continuous dopaminergic stimulation Horowski, R.

79 S1 p. e72-e73
artikel
238 Long-term effect of non-invasive Vagus Nerve in patients with Parkinson's disease: A randomized double blind controlled study Mondal, B.

79 S1 p. e61
artikel
239 Long-term effect of transcranial magnetic stimulation on hypokinetic dysarthria in Parkinson's disease and its neural underpinnings Brabenec, L.

79 S1 p. e56-e57
artikel
240 Long term outcome of Parkinson's disease and validation of a new clinical classification system Rödström, E. Ygland

79 S1 p. e35-e36
artikel
241 Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson's disease: 10 years and beyond Park, H.R.

79 S1 p. e15
artikel
242 Long-term treatment with valbenazine 40 mg once-daily in adults with Tardive dyskinesia Chepke, C.

79 S1 p. e119-e120
artikel
243 Loss of Fragile X Mental Retardation Protein (FMRP) precedes Lewy pathology in Parkinson's Disease Koeglsperger, T.

79 S1 p. e73
artikel
244 Low diagnostic accuracy for an early clinical diagnosis of Parkinson's Disease Adler, C.

79 S1 p. e73-e74
artikel
245 Lower Urinary tract symptoms in spinocerebellar ataxias Jang, M.

79 S1 p. e113
artikel
246 Mechanism of osteoporosis in patients with Parkinson's disease Suzuki, Y.

79 S1 p. e81
artikel
247 Medical follow up assessments of iPrognosis application users for early Parkinson's disease detection Klingelhoefer, L.

79 S1 p. e37
artikel
248 Metabolic profiles of serum and putamen in Parkinson's disease Michałowska, M.

79 S1 p. e7
artikel
249 Metronidazole induced cerebellar ataxia: first 2 case reports from Thailand Wantaneeyawong, C.

79 S1 p. e111
artikel
250 Microglia implicated in tau proteostasis disturbances in the striatum of neurodegenerative disease patients from genotype to phenotype Li, H.

79 S1 p. e5
artikel
251 Mild cognitive impairment in patients with Parkinson's disease and the analysis of associated factors Tur, E. Kobak

79 S1 p. e25-e26
artikel
252 miRNA sequencing from routine colonic biopsies reveals an enrichment of mucosal hsa-miRNA-486-5p in Parkinson's disease Kurz, A.

79 S1 p. e79
artikel
253 Mirtazapine - an underrated drug for L-dopa induced dyskinesias Verma, O.

79 S1 p. e70
artikel
254 Modeling Parkinson's Disease by damaging dopaminergic neurons Turaeva, G.

79 S1 p. e95
artikel
255 Models of Parkinson's disease in vitro Azizova, D.

79 S1 p. e92-e93
artikel
256 Molecular imaging correlates of sleep dysfunction in Parkinson's disease (PD) Nene, D.

79 S1 p. e13
artikel
257 morphological changes of retina in patients with Parkinson's disease and the role of α-synuclein in retinal damage Luo, M.

79 S1 p. e51
artikel
258 Motor and cognitive dontributions of dual-task walking deficits in people with Parkinson's disease Sawada, H.

79 S1 p. e122-e123
artikel
259 Motor response inhibition - A potential tool to determine optimum STN-DBS parameters Basu, P.

79 S1 p. e43-e44
artikel
260 Music therapy approaches in meeting quality of life goals in patients with Parkinson's Disease and related disorders Wellman, B.

79 S1 p. e125
artikel
261 Music therapy in Parkinson's disease Rakhimova, M.

79 S1 p. e123
artikel
262 Mutational analysis of SLC6A3 gene in Parkinson's disease (PD) patients in Coimbatore Population, India Iyer, M.

79 S1 p. e32
artikel
263 Myelin water imaging: Potential white matter biomarker in Parkinson's Disease Septian, H.

79 S1 p. e10
artikel
264 Natural history of lung function in patients with Parkinson's disease (PD) over one year Kaminsky, D.A.

79 S1 p. e33
artikel
265 Neural correlates of visuospatial dysfunction in Parkinson's Disease: A multimodal biomarker study Cucca, A.

79 S1 p. e40
artikel
266 Neuroacanthocytosis: Beyond movement disorders Surisetti, B.K.

79 S1 p. e108
artikel
267 Neuroprotective effect of L-theanine against chronic Tramadol induced motor deficit and dopaminergic neurodegeneration in experimental rats Singh, S.

79 S1 p. e84-e85
artikel
268 New methods of education in movement disorders for medial students Ilyazova, A.

79 S1 p. e90-e91
artikel
269 New RAS based rehabilitation tool for Parkinson disease gait impairment management Hoffnung, D.

79 S1 p. e125
artikel
270 Nighttime and morning OFF improvements with opicapone in patients with Parkinson's Disease and motor fluctuations: BIPARK-1 and BIPARK-2 pooled subanalyses Hauser, R.A.

79 S1 p. e53-e54
artikel
271 Nilotinib alters microRNAs that regulate specific autophagy and ubiquitination genes in the CSF of individuals with Parkinson's disease Torres-Yaghi, Y.

79 S1 p. e55
artikel
272 Nilotinib increases brain dopamine and lowers CSF tau and oligomeric alpha-Synuclein in Parkinson's disease Moussa, C.

79 S1 p. e4
artikel
273 Nilotinib is reasonably safe and may halt the disease progression in moderately severe Parkinson's disease patients Pagan, F.

79 S1 p. e71
artikel
274 Non-Motor Fluctuations in Parkinson's Disease (PD): Development and Validation of the Non-Motor Fluctuation Assessment Instrument (NoMoFA) Margolius, A.

79 S1 p. e40-e41
artikel
275 Non-motor symptoms and health-related quality of life in Vietnamese patients with young onset Parkinson's Disease Ha, U.N.-L.

79 S1 p. e46
artikel
276 Non motor symptoms in idiopathic Parkinson's disease and atypical parkinsonism - a comparative analysis Grażyńska, A.

79 S1 p. e88
artikel
277 Non-motor symptoms in Parkinson's disease patients in Kyrgyzstan Zhunusova, E.

79 S1 p. e96
artikel
278 Non-permitted food colorants induced neurobehavioral toxicity in cerebellum of rats Biswas, P.

79 S1 p. e118-e119
artikel
279 Nose to brain delivery of embelin with carbidopa nanoparticle for effective management of Parkisonism Jain, S.

79 S1 p. e65
artikel
280 NPC1 variants are not associated with Parkinson's disease Senkevich, K.

79 S1 p. e31
artikel
281 Nutritional determinants of quality of life in patients with Parkinson's disease Botello, C.K. López

79 S1 p. e49
artikel
282 Oculomotor abnormalities in patients with Parkinson's disease and progressive supranuclear palsy Koçoğlu, K.

79 S1 p. e40
artikel
283 OFF/-ON-time changes after switching from entacapone or placebo to opicapone in patients ending the BIPARK-I extension study on opicapone 50-mg Poewe, W.

79 S1 p. e59-e60
artikel
284 Onset of action for rimabotulinumtoxinB in the treatment of adult sialorrhea Bahroo, L.

79 S1 p. e56
artikel
285 Onset of drug-related adverse events in Parkinson's disease patients treated with opicapone in clinical practice: OPTIPARK post-hoc analysis Lees, A.

79 S1 p. e61-e62
artikel
286 Opicapone as first-line adjunctive levodopa treatment in Parkinson's disease patients with motor fluctuations: BIPARK-I and II combined post-hoc analysis Ferreira, J.J.

79 S1 p. e63
artikel
287 Opicapone in clinical practice in Parkinson's disease patients with motor fluctuations: findings from the OPTIPARK study Reichmann, H.

79 S1 p. e62
artikel
288 Opicapone's added benefit as a first-line adjunctive therapy to levodopa and when used promptly for motor fluctuations in Parkinson's disease Ebersbach, G.

79 S1 p. e71-e72
artikel
289 Optimizing CNS-delivery by Lactyl stearate-coupled liposomes Bhargava, M.

79 S1 p. e116-e117
artikel
290 Oral administration of squalamine protects rats from parkinsonism Subramanian, T.

79 S1 p. e4
artikel
291 Outcomes in transcranial direct current stimulation studies among people with Parkinson's disease. A scoping review Etoom, M.

79 S1 p. e124-e125
artikel
292 Outcomes of a prospective, multicenter, international registry of Deep Brain Stimulation for Parkinson's Disease Deuschl, G.

79 S1 p. e49-e50
artikel
293 Pain as one of the symptom of Parkinson's disease in Uzbekistan patients Murodova, N.

79 S1 p. e41
artikel
294 Pain in young onset parkinson disease: prevalence, characteristics and associated factors HuyenThi Dang, T.

79 S1 p. e37
artikel
295 Pain syndromes in Parkinsonism depending on the form Nurmuxamedova, N.

79 S1 p. e25
artikel
296 Parkinson disease and the law: motor and non-motor determinants in medical courts cases Amami, P.

79 S1 p. e78
artikel
297 Parkinson's disease caregiving burden in Singapore Prakash, K.M.

79 S1 p. e78-e79
artikel
298 Parkinson's disease modeling analysis Mikliev, Z.

79 S1 p. e92
artikel
299 Patient perspective of Tardive dyskinesia: Results from a Social Media Listening Study Lundt, L.

79 S1 p. e117
artikel
300 Patient-reported motor responses to apomorphine sublingual film based on home dosing and response diaries Hauser, R.

79 S1 p. e74-e75
artikel
301 Patterns of worsening physical and mental characteristics in PD patients affected by major earthquakes Kurisaki, R.

79 S1 p. e78
artikel
302 Peak-dose ballism associated with declining implantable pulse generator battery life in deep brain stimulation for Parkinson's disease Chong, D.

79 S1 p. e15
artikel
303 Peripheral neuropathy in de novo patients with Parkinson's disease Baik, J.S.

79 S1 p. e75
artikel
304 Persistence with treatment as the basis of successful treatment for Wilson disease Kraśniej-Dębkowska, A.

79 S1 p. e100
artikel
305 Pharmacokinetics of inhaled levodopa (administered with oral carbidopa) and oral carbidopa/levodopa in subjects with Parkinson's disease under fed conditions Safirstein, B.E.

79 S1 p. e68
artikel
306 Pharmacological treatment of apathy in Parkinson's disease, review of the literature Overvliet, G.

79 S1 p. e70-e71
artikel
307 Phenotypic heterogeneity in Chinese dystonia patients with KMT2B variants Li, X.-Y.

79 S1 p. e105
artikel
308 Phonetic but not semantic verbal fluency impairment based on side-onset in Lewy body diseases Lucas-Jiménez, O.

79 S1 p. e22
artikel
309 Physical treatment of Parkinson's disease Amraeva, G.

79 S1 p. e65-e66
artikel
310 Physician preferences for levodopa-carbidopa intestinal gel as monotherapy versus combination therapy for advanced Parkinson's disease: Analysis from the COSMOS study Fasano, A.

79 S1 p. e45
artikel
311 Physiotherapy may improve non-motor burden in people with Parkinson's disease De Waele, S.

79 S1 p. e54
artikel
312 Polymorphic reference SVAs are associated with Parkinson's Disease progression markers and differential gene expression in the PPMI cohort Pfaff, A.

79 S1 p. e30
artikel
313 Predictors of quality of life in Parkinson's Disease Sanchez-Luengos, I.

79 S1 p. e18
artikel
314 Prevalence and characteristics of postural deformities in Thai patients with Parkinson's Disease Wangthumrong, T.

79 S1 p. e36-e37
artikel
315 Prevalence of and factors associated with cognitive impairment in multiple system atrophy with different disease durations Zhang, L.

79 S1 p. e99
artikel
316 Prevalence of and factors related to pathological laughter and crying in patients with multiple system atrophy with different disease durations Zhang, L.

79 S1 p. e97-e98
artikel
317 Prevalence of restless leg syndrome (RLS) in Parkinson's disease and its correlation with serum and CSF iron and ferritin levels Kandadai, R.M.

79 S1 p. e51-e52
artikel
318 Prevention of suffering with subcortical parkinsonian dementia Sokhibnazarov, N.

79 S1 p. e24-e25
artikel
319 Primary headaches as non-motor symptoms in demyelinating diseases Gulova, M.

79 S1 p. e122
artikel
320 Progression of pathologic atrophy in patients with Huntington disease in Uzbekistan Kalandarova, S.

79 S1 p. e103
artikel
321 Progressive supranuclear palsy initially misdiagnosed as Hashimoto encephalopathy Ivaniuk, A.

79 S1 p. e102
artikel
322 Pro-saccades impairment in Parkinson's disease Akkoyun, M.

79 S1 p. e37-e38
artikel
323 Prospective follow up of the patients with Schizophrenia accompanied by Parkinsonism Yoritaka, A.

79 S1 p. e103
artikel
324 Proteasomal degradation of alpha synuclein by induction of heat shock proteins in Parkinson's disease Adebisi, B.

79 S1 p. e31
artikel
325 Protective effects of HIF-1-induced p62 and sestrin2 in 1-methyl-4-phenylpyridinium (MPP+)-mediated cytotoxicity in PC12 cells Yang, D.-I.

79 S1 p. e82-e83
artikel
326 Psychocorrection of children with ticose hyperkinesis Maxamatjanova, N.

79 S1 p. e108
artikel
327 Quantitative assessment of In-Vitro effects of selected cognitive and nootropicdrugs on mitochondrial energy metabolism: A systematic study against neurodegenerative disorders Singh, N.

79 S1 p. e24
artikel
328 Quantitative gait and postural analyses in patients with diabetic polyneuropathy Park, J.

79 S1 p. e118
artikel
329 Race, language, and technology status: How to close the gap in Parkinson's Disease research participation Bird, K.

79 S1 p. e80
artikel
330 Rapidly onset progressive generalised dystonia parkinsonism in a young Indian male with rare FBOX 7 genetic mutation Desai, S.

79 S1 p. e97
artikel
331 Real world clinical outcomes using a novel directional lead from a multicenter registry of deep brain stimulation for Parkinson's Disease Deuschl, G.

79 S1 p. e50
artikel
332 Real-world evaluation of patient characteristics and disease management in long-term valbenazine treatment in adults with Tardive dyskinesia Siegert, S.

79 S1 p. e117-e118
artikel
333 Related with risk factors of depression in Parkinson's disease at high altitude Zhu, A.

79 S1 p. e24
artikel
334 Relationship between anxiety of falling and motor function in Parkinson's disease patients during daily activities Yamaguchi, Y.

79 S1 p. e119
artikel
335 Relationship between clinical symptoms and ageing, Parkinson Disease Dagvadorj, B.

79 S1 p. e48
artikel
336 Relationship between impulse control disorders and preexisting type 2 diabetes mellitus in drug naïve Parkinson's Disease patients Kovács, M.

79 S1 p. e19-e20
artikel
337 Relationship between restless legs syndrome and motor subtype in patients with de novo Parkinson's disease Choi, S.-M.

79 S1 p. e34
artikel
338 Relationship between vitamins and minerals intake with Parkinson disease stages López-Botello, C.K.

79 S1 p. e41
artikel
339 REM sleep behavior disorder in early Parkinson's disease predicts the rapid progression of dopaminergic denervation Kim, Y.E.

79 S1 p. e34
artikel
340 REM sleep without atonia affects sleep architecture in multiple system atrophy Saitoh, Y.

79 S1 p. e102-e103
artikel
341 Resting state functional connectivity in levodopa non responsive Parkinson's disease patients with freezing of gait Sreenivasan, K.

79 S1 p. e8
artikel
342 Resting-state network connectivity in newly diagnosed drug-naïve Parkinson's disease patients with mild cognitive impairment Hou, Y.

79 S1 p. e11
artikel
343 Reversible hemichorea caused by bilateral diabetic striatopathy in a patient with Fahr's syndrome Kim, Y.-K.

79 S1 p. e109
artikel
344 Role of dopamine Transporter Scan (DaTscan) imaging in the evaluation of Parkinsonism: Experience from a tertiary care center Doss, S.

79 S1 p. e13
artikel
345 Safinamide for patients without motor fluctuations - is it useful? Barreto, R.

79 S1 p. e67
artikel
346 Scaling up the scales; one scale to combine them all Carpentier, A. Veilleux

79 S1 p. e46
artikel
347 Screening of mutations in PARK2 gene and Dopamine levels in Parkinson's disease (PD) patients in Coimbatore population, India Vellingiri, B.

79 S1 p. e29-e30
artikel
348 Secondary vascular manifestation of parkinsonism syndrome with chronic cerebral ischemia in Uzbekistan Rajabov, A.

79 S1 p. e53
artikel
349 Senataxin gene mutation presenting with ataxia oculomotor apraxia type 2: Five patients with three different mutations Seçil, Y.

79 S1 p. e112
artikel
350 Sensory trick in a patient with Wilson's Disease Shambetova, C.

79 S1 p. e107
artikel
351 Sequencing the entire exome of REM sleep behavior and progression to neurodegenerative diseases Saini, P.

79 S1 p. e26-e27
artikel
352 Severity of motor symptoms in Parkinson's disease in Kazakhstan (on the example of the city of Almaty) Aralbayeva, A.

79 S1 p. e91
artikel
353 Sleep and Polysomnographic abnormalities in Indian patients with Huntington's disease Yadav, R.

79 S1 p. e107-e108
artikel
354 Sleep changes and epileptiform discharges in Parkinson's and Alzheimer's disease: 24-hour EEG study Papp, A.

79 S1 p. e51
artikel
355 Some aspects of comparative evaluation of cognitive disorders in patients with vascular Parkinsonism and Parkinson's disease Okhunova, D.

79 S1 p. e21-e22
artikel
356 Spectrum of disorders presenting as secondary Parkinsonism in a rural based medical teaching college in Western India Desai, D.

79 S1 p. e101
artikel
357 Speech difficulties as a first symptom of progressive supranuclear palsy: a case report Strelchenko, E.

79 S1 p. e101
artikel
358 Status Dystonicus Korkmaz, M.

79 S1 p. e105
artikel
359 Structural alteration of brain cholinergic systems in a prodromal state of synucleinopathy: The idiopathic REM sleep behaviour disorder Bedard, M.A.

79 S1 p. e13
artikel
360 Structural and functional parameters of retina in patients with Huntington's disease Kopal, A.

79 S1 p. e6-e7
artikel
361 Studies on the role of neurosteroids in Parkinson's disease dementia Okhunova, D.

79 S1 p. e48
artikel
362 Study design and rationale for an international study of DBS for movement disorders Pahwa, R.

79 S1 p. e17
artikel
363 Study of aqueous extract of Terminalia chebula and Allophylus serratus aluminium-induced neurotoxicity: Relevance to sporadic amyotrophic lateral sclerosis Rajput, S.

79 S1 p. e121
artikel
364 Study of clinical efficiency and portability of the Pramipexol BIO product Musaev, S.

79 S1 p. e66
artikel
365 Study of variability in tremor in Parkinson's Disease population Meka, S.S.L.

79 S1 p. e52
artikel
366 Suicidal and death ideation in early-onset Parkinson's disease Ou, R.

79 S1 p. e39
artikel
367 Switches between device aided treatment options in advanced Parkinson's disease Delalić, S.

79 S1 p. e77-e78
artikel
368 Symptomatic brainstem reflex myoclonus (Hyperekplexia) in a patient with Bickerstaff's brainstem encephalitis (BBE) Sudath, I. Ravindra

79 S1 p. e114-e115
artikel
369 Synthesis and pharmacological evaluation of 16-imidazolyl substituted heterosteroids in LPS induced neuroinflammation model of rat for antiparkinsonian and antioxidant effects Singh, R.

79 S1 p. e71
artikel
370 Systematic walking speed training on a treadmill to improve gait performance in patients with Parkinson's disease van Wegen, E.

79 S1 p. e70
artikel
371 Telemedicine tailored to patient's needs: Assessing usability and user experience in patients with Parkinson's disease Bendig, J.

79 S1 p. e73
artikel
372 The Association between anti-hypertensive and beta-agonist drugs and risk of Parkinson's Disease: a large meta-analysis study Addai, M.F.

79 S1 p. e77
artikel
373 The connection of akinetic-rigid syndrome with the etiology of various Parkinsonism syndromes Kuzieva, S.

79 S1 p. e88
artikel
374 The effect of deep brain stimulation surgery on the non-motor symptoms in Parkinson's disease van der Zee, S.

79 S1 p. e23
artikel
375 The effect of isoniazid on the tremor-predominant Parkinson's disease Saydaliev, S.

79 S1 p. e67-e68
artikel
376 The effect of nigral dopaminergic depletion on the morphology of striatal medium spiny neurons in the MPTP mouse model Witzig, V.

79 S1 p. e3
artikel
377 The effect of severity of Parkinson's disease on migraine Ahn, J.-Y.

79 S1 p. e92
artikel
378 The financial burden of Parkinson's disease is greater for caregivers of people experiencing OFF periods Abeynayake, I.

79 S1 p. e86
artikel
379 The genetic landscape of hereditary spastic paraplegia in Canada Estiar, M.A.

79 S1 p. e110
artikel
380 The immune mechanism of LAG3 in MPTP model Guo, W.

79 S1 p. e82
artikel
381 The impact of motor and non-motor wearing-off on the quality of life of patients with Parkinson's disease Abdurakhmonova, K.

79 S1 p. e89
artikel
382 The importance of brain-derived neutrophic factor for lipid profile among Parkinson's patients Alomari, M.

79 S1 p. e81-e82
artikel
383 The incidence of non-motor disorders in Parkinson's disease and vascular parkinsonism Naimov, O.

79 S1 p. e25
artikel
384 The largest monocentric study on sex distribution, penetrance, incidence, and association with dementia of GBA mutations in Parkinson's disease Straniero, L.

79 S1 p. e28-e29
artikel
385 The prevalence of essential tremor in Edirne and its counties accompanied comorbid conditions Guler, S.

79 S1 p. e115-e116
artikel
386 The protective effects of iron chelators inhibiting ferroptosis in PD in vivo Zeng, X.

79 S1 p. e75
artikel
387 The Rehabilitation of functional synkinesia reduction at patients with Parkinson's disease Mirdedaev, S.

79 S1 p. e69
artikel
388 The relationship between hypercritisolemia and impaired bioimpedansitometric parameters and its role in the development of cognitive impairment in Parkinson's disease Akramova, D.

79 S1 p. e18-e19
artikel
389 The relationship between ON-Freezing of Parkinson disease and Sensory Organization Park, J.H.

79 S1 p. e120
artikel
390 The role apomorphine as a potential modifier of amyloid deposition in Parkinson's disease Rakhimov, F.

79 S1 p. e57-e58
artikel
391 The role of environmental toxins (Rotenone) in Parkinson's Disease Tursunov, D.

79 S1 p. e94-e95
artikel
392 The role of microRNA in Parkinson's disease Aralbayeva, A.

79 S1 p. e79
artikel
393 The Yale technique of Botulinum toxin injections for Parkinson's disease and essential tremor - Customised treatment for effective and safe therapy Mittal, S.

79 S1 p. e57
artikel
394 Tissue biomarker for the detection of dementia with Levi bodies Azizova, D.

79 S1 p. e84
artikel
395 To study the medication adherence patterns in Parkinson's disease and it's impact on quality of life Mahajan, N.

79 S1 p. e74
artikel
396 Tractography of the corticospinal tract in Parkinson's Disease. How does diffusion values vary along tract segments? Guimarães, R.

79 S1 p. e12
artikel
397 Transcription factor Nurr1 in dopamine neuron development and neurodegeneration associated with Parkinson's disease Le, W.

79 S1 p. e28
artikel
398 Treatable vitamin deficiencies in Parkinson's Disease: A case for routine screening  Smith, E.

79 S1 p. e82
artikel
399 Tremorin model of Parkinson's disease Tukhtamishev, M.

79 S1 p. e95-e96
artikel
400 Trimetazidine treatment in Parkinson's Disease: Is it a real problem or just a flame? Pintér, D.

79 S1 p. e75
artikel
401 Two commercial brands of levodopa/carbidopa (LD/CD) tablets producing different therapeutic effects in 3 patients of advanced Parkinson's disease(PD) Shukla, K.

79 S1 p. e54-e55
artikel
402 UPDRS motor-score improvement after CVT-301 treatment is associated with improved scores in Parkinson's Disease Questionnaire (PDQ-39) activities of daily living Hauser, R.A.

79 S1 p. e68
artikel
403 Up-regulation of miR-409-3p in cerebrospinal fluid of Parkinson's disease reduce the apoptosis of dopamine neurons Tan, X.

79 S1 p. e10-e11
artikel
404 Usefulness of the odor stick identification test for patients with Parkinson's disease Stepanchenko, K.

79 S1 p. e9
artikel
405 Utility of clinical exome sequencing in dystonia: A report from India Neeraja, K.

79 S1 p. e104
artikel
406 Utilization of new visualization software for DBS programming using a multiple-source, constant-current rechargeable system Aldred, J.

79 S1 p. e52
artikel
407 Validation of the Parkinson fatigue scale in Turkish Parkinson's disease patients Guler, S.

79 S1 p. e92
artikel
408 Validity of a physical activity tracker for heart rate measurement during aerobic exercise in people with Parkinson's disease Mak, M.

79 S1 p. e42-e43
artikel
409 Vascular Parkinsonism (VP) score: A simple clinical scale to differentiate vascular from degenerative parkinsonism Acharya, M.

79 S1 p. e98
artikel
410 Vertical vision problem assessment in patients with Parkinson's disease Magzumov, N.

79 S1 p. e79-e80
artikel
411 Visual complaints and disorders in patients with Parkinson's disease van der Lijn, I.

79 S1 p. e18
artikel
412 Vitamin D receptor mutations influence on course of Parkinson's disease in patients treated with L-Dopa Koper, J.

79 S1 p. e32-e33
artikel
413 Vitamin D supplementation helps to struggle musculoskeletal pain in Parkinson's disease - Clinical case study Sahakyan, G.

79 S1 p. e66-e67
artikel
414 Vowel articulation index and conversational spontaneous speech intelligibility in Parkinson's disease Rountrey, C.

79 S1 p. e123
artikel
415 Vowel speech analysis for Parkinson's Disease Wen, Y.

79 S1 p. e101-e102
artikel
416 Waiting on dopamine transporter imaging in drug induced parkinsonism Yun, J.Y.

79 S1 p. e45
artikel
417 Walking with music is a safe and viable tool for balance, functionality and, mobility in Parkinson's Disease Huzmeli, E. Dogru

79 S1 p. e90
artikel
418 WITHDRAWN: Etiological structure of stroke and secondary extrapyramidal hyperkinesis Omonov, B.

79 S1 p. e104
artikel
                             418 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland